Domov › Crohnova choroba › Florida › Orlando
Klinické štúdie Crohnova choroba v meste Orlando, FL
17 štúdií pre Crohnova choroba hľadá účastníkov v zariadeniach v meste Orlando a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Prebieha náborFáza 3
- AdventHealth Orlando ( Site 5131), Orlando
- Endoscopic Research Inc ( Site 5061), Orlando
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Prebieha náborFáza 2
- Digestive And Liver Center Of Florida - Orlando /ID# 280924, Orlando
- Clinical Research of Osceola /ID# 280593, Kissimmee · 16 míľ odtiaľ
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Prebieha náborFáza 4
- Endoscopic Research, Inc., Orlando
- Orlando Health-Orlando Regional Medical Center, Orlando
- Digestive and Liver Center of Florida, P.A., Kissimmee · 16 míľ odtiaľ
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Prebieha náborFáza 2
- Endoscopic Research, Inc. /ID# 267211, Orlando
- Novum Research /ID# 278128, Clermont · 24 míľ odtiaľ
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 2
- AdventHealth (Florida Hospital) Medical Group, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Prebieha náborFáza 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 3
- AdventHealth Orlando-Site Number: 8400070, Orlando
- Orlando Health, Inc.-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 míľ odtiaľ
- a 1 ďalších
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 3
- Orlando Health, Inc., Digestive Health Institute-Site Number: 8400084, Orlando
- Clinical Research of Osceola-Site Number: 8400013, Kissimmee · 16 míľ odtiaľ
A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 3
- Arnold Palmer Hospital for Children Center Digestive Health and Nutrition-Orland /ID# 255437, Orlando
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 2
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · 16 míľ odtiaľ
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
Prebieha náborFáza 4
- Endoscopic Research Inc, Orlando
- Clinical Research of Osceola, Kissimmee · 16 míľ odtiaľ
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Prebieha nábor
- Advent Health, Orlando
Zymfentra (Infliximab-dyyb) REal World Cohort STudy
Prebieha náborObservačná štúdia
- AdventHealth, Orlando
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD
Prebieha náborFáza 4
- Digestive & Liver Center of Florida, Orlando
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Prebieha náborFáza 2
- Orlando Health, Inc., Orlando
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Prebieha náborFáza 2
- Investigational Site Number: 8400007, Orlando
- Investigational Site Number: 8400017, Kissimmee · 16 míľ odtiaľ
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Prebieha náborFáza 2
- Mirador Therapeutics Selected Site, Orlando
Štúdie Crohnova choroba v iných mestách
- New York City, NY35 štúdií
- Cleveland, OH19 štúdií
- St. Louis, MO19 štúdií
- Boston, MA19 štúdií
- Miami, FL19 štúdií
- Houston, TX17 štúdií
- Atlanta, GA17 štúdií
- Tyler, TX16 štúdií
- San Diego, CA15 štúdií
- San Antonio, TX15 štúdií
- Los Angeles, CA15 štúdií
- Philadelphia, PA13 štúdií
Iné štúdie v Orlando
- Nemalobunkový karcinóm pľúc44 štúdií
- Obézita31 štúdií
- Metastatická rakovina29 štúdií
- Nadváha27 štúdií
- Alzheimerova choroba25 štúdií
- Diabetes mellitus 2. typu24 štúdií
- Rakovina (všetky typy)24 štúdií
- Rakovina prsníka23 štúdií
- Rakovina vaječníkov22 štúdií
- Ulcerózna kolitída22 štúdií
- Rakovina pľúc21 štúdií
- Kolorektálny karcinóm19 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.